1[1]Y Sun,D Peng, J Lecanda et al. In vivo gene transfer of CD40 ligand into colon cancer cells induces local prdoducation of cytokines and chemokines,tumor eradication and protective antitumor eradication and protective antitumor immunity. Gene Therapy,2000;7:1467-1476
2[2]Leo Lefrancois, John D. Altman, Kristina Williams, etc. Soluble antigen and CD40 triggering are sufficient to induce primary and memory cytotoxic T cells. The Journal of Immunology,2000; 164:725～732
3[3]Regis T, Costello, Jean-Albert Gastaut et al. What is the real role of CD40 in cancer immunotherapy? Immunology Today, 1999 (Nov), 20(11):488-492
4[4]P. Mendez-Samperio, H. E. Ayala-Verdin, A. Trejo-Echeverria. Intereukin-12 regulate the production of bacil Calmette-G uerin-lnduced intreferon-γ from human cells in a CD40-dependet manner. Scand. J Immunol,1999,50,61-67
5[5]Linda Diehl, Annemieke Th, Den Boer et al. CD40 activation in vivc overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy. Nature Medicine, 1999, Vol 5(7) :774-779
6[6]R. M. Egeler, B.E. Favara, J. D. Laman et al. Abundant expression of CD40 and CD40-ligand(CD154) in peadiatric Langerhans cell histiocytosis lesions. European Journal of Cancer,2000,36:2105-2110
7[7]Lome F Erdile, Darlene Smith. CD40 activatin enhances the magnitude of cellular immune response against p53 but not the avidity of the effectors.Cancer Immunol. Immunother, 2000,49: 410-416
8[8]Ype P De Jong, Martina Comiskey,Susan L. Kalled et al. Chronic murine colitis is dependet on CD154/CD40 pathway and can be attenuated by anti-CD154 administration. Gastroenterology, 2000,119:715-723
9[9]Chao-Zhou Ni,Kate Weish,Eugen L eo, Chu-kuan Ch iou et al. Molecular basis for CD40 signaling mediated by TRAF3.PNAS,97(19): 10395-10399
2Braunwald E, Antman EM, Beasley JW et la. ACC/AHA guidelines for the management of patients with unstable angina and no-ST-segment elevation myocardial infarction. A report of American College of Cardiology/American Heart Association Task Force or Practice Guide-lines (Committee on the Management of Patients with Unstable Angina) [J]. J Am Coil Cardio, 2000, 36 (3): 970-1062.
